演讲嘉宾
Filter by:
Gil Addo, SVP, Specialty Care Solutions, Health Care Delivery, CVS Health
Gil Addo is CEO and Co-Founder of RubiconMD, a wholly-owned subsidiary of Oak Street Health. RubiconMD’s digital health platform empowers primary care clinicians with access to virtual specialty care from top medical specialists to improve patient care. Founded in 2013, RubiconMD serves primary care clinicians across 37 states. The Huffington Post named RubiconMD one of the “Five Companies Defining the Future of Healthcare” and, in 2020, AllianceBernstein ranked RubiconMD number 12 on its list of the top 25 private companies disrupting healthcare. Prior to founding RubiconMD, Gil was a Consultant at Putnam Associates, a pharma strategy consultancy, where he designed payer and market access strategies for Fortune 500 clients. He previously held strategy and business development roles at Xerox, Cubist (acquired by Merck), and two early-stage healthcare ventures. Gil has appeared in Inc., Forbes, CNBC, Fortune, and Entrepreneur Magazine. He’s been named one of Forbes’ “30 Under 30” in healthcare, Crains New York’s Business 40 Under 40, and Business Insider’s 30 under 40 in healthcare. In 2020, Crains New York named Gil to its list of the Most Notable in Health Care and in 2017, he received their Heritage Healthcare Innovator of the Year award. He holds a BS in Economics and Biomedical Engineering from Yale and an MBA from Harvard.
Payal Agrawal Divakaran, Partner, .406 Ventures
Payal is a Partner at .406 Ventures, where she co-leads the digital health investing practice. .406 Ventures is a Boston-based venture capital firm with ~$1B under management. The firm invests in enterprise-oriented start-ups in sectors including digital health, cybersecurity, and data & cloud. Payal’s portfolio includes AristaMD, Better Life Partners, Diana Health, Equip, Heartbeat Health, Nomad Health, Redox, Wayspring, WelbeHealth, Wellist, and Virtudent. Previously, Payal co-founded a company called SpotRocket to help students discover high-potential start-ups to work for. Payal has also worked at Eventbrite, Spectrum Equity, and J.P. Morgan. Payal received her MBA, with Distinction, from Harvard Business School and her BS in Electrical Engineering and minor in Management from MIT. She is a Boston native and she and her husband, who is a physician at Brigham and Women’s Hospital, and two kids live in Brookline.
Caesy Albert, Managing Partner, SteelSky Ventures
Casey Albert is a Managing Partner at SteelSky Ventures, an early-stage venture fund investing at the intersection of technology and healthcare. She leads SteelSky’s Executive Council, which includes senior executives from Eli Lilly, Blue Shield of California, Stanford Children’s Hospital, and other leading healthcare companies. Casey has spent over 25 years investing in and scaling companies that accelerate access to healthcare. As Managing Director at Founders Factory, she oversaw new company creation and seed-stage investments in consumer health, medical devices, and life sciences, with strategic LP Johnson & Johnson. Prior to that, as head of Technology and Innovation at R4D, Casey advised senior decision-makers and innovation teams embedded in the governments of the US, UK, Canada, Australia, and Korea, on leveraging technology for healthcare innovation. Casey began her career at Deloitte, working in over 15 countries to strengthen health systems. A frequent speaker on venture investing, healthcare, and technology, Casey holds a BA from Wellesley College and an MBA and MPP from Columbia University.
Gaye Bok, Former, Partner AI & Digital Innovation Fund, Innovation, Mass General Brigham Innovation
Gaye Bok leads Mass General Brigham’s $30M AI and Digital Innovation Venture Fund (AIDIF), investing in commercial-stage digital health companies, working with the Mass General Brigham system. Prior to joining Mass General Brigham, Gaye was a venture partner at an institutional venture fund, where she was an integral part of the investment team and served as a board director on several portfolio companies. Prior to venture investing, Gaye was an experienced commercial and business development executive, focused mainly on developing products and strategic partnerships across several verticals: Chemicals, genomics, biobased energy, and biobased products. Gaye received an MBA in finance and international management from MIT’s Sloan School and an AB from Harvard and Radcliffe Colleges.
Carine Carmy, Co Founder & CEO, Origin Physical Therapy
I'm an entrepreneur, go-to-market expert, and writer. Deep interests in healthcare, technology, people operations, and the future of work. CEO and Co-Founder at Origin: physical therapy, designed for women and mothers. We offer expert care for your whole body (including your vagina), both online and in-person. Operating as Bebé Physical Therapy since 2007 in Los Angeles, California, Origin has treated thousands of women with overlooked but incredibly common female health issues, helping them to build strength and avoid countless unnecessary surgeries. Previously, I launched and led marketing, sales, and customer success at Amino, a digital health company that guides individuals to higher quality, lower cost care. Prior to Amino, I worked in 3D printing as VP of Marketing at Shapeways and also helped found MarketspaceNext, a boutique digital strategy firm we spun out of Monitor Group (now Monitor Deloitte). I teach strategy & marketing at General Assembly and manage a community of startup growth leaders. I’m a nonprofit advisor, supporting organizations focused on diversity, economic equality, and the ethics of technology and business. A graduate of the University of Pennsylvania, I’ve conducted research on science, technology, and economic trends for The Milken Institute and Center for Bioethics at Penn.
Ian Chiang, Partner, Flare Capital Partners
Ian is a Partner at Flare Capital, led the firm’s investment into Knownwell and was an essential part of the firm’s investments in Inbound Health and RightMove, where he serves as a board member, as well as Cayaba Care, and Oshi Health. Additionally, Ian led the firm’s Flare Scholar Ventures investments in Adni, EarlyBird Education, Narrable, and Vincere Health. Prior to joining Flare Capital, Ian served as a Senior Vice President and a founding member of CareAllies, Cigna’s family of multi-payer provider services, population health management, and home-based care businesses. In that capacity, he was responsible for developing new technology-enabled services, evolving existing solutions and service lines, and providing ongoing product management across CareAllies’ businesses. In addition, he was also responsible for developing inorganic strategies for CareAllies since its inception. Before launching CareAllies, Ian held a leadership position with Cigna’s US Strategic Operations team. Ian was a co-founder of several start-ups, including XcelDx, which ultimately partnered with Scanwell Health, a smartphone-enabled diagnostics company backed by Y-Combinator, Founders Fund, DCM, Version One, and Mayfield. He focused his efforts on product development and served as an advisor to the company. Scanwell was acquired by BD (Becton, Dickinson and Company) in 2021. He also worked for Becton, Dickinson & Company, where he led new product innovation and development. He continues to actively advise and mentor a number of innovative healthcare start-ups. He started his career at McKinsey & Company and spent five years advising healthcare clients globally. Ian serves as an advisor and board member of various organizations. He is currently a member of the Board of Directors at The New England Venture Capital Association and Harvard Business School Healthcare Alumni Association, where he also served as the 2021 Annual Conference Co-Chair. Additionally, Ian serves as an Industry Advisor at Cornell Tech’s The Precision Behavioral Health Initiative. Ian has a Bachelor of Science degree in biological engineering from Cornell University, where he graduated with honors and was a Cornell Presidential Research Scholar. He also holds an MBA from Harvard Business School.
Caitlin Donovan, Partner, General Catalyst
Caitlin Donovan is a highly recognized builder and operator in the healthcare space who shares our commitment to make health assurance a reality - where healthcare is more accessible, proactive and affordable for all. Caitlin was most recently the Global Head of Uber Health, Uber’s business unit focused on creating a first-of-its-kind supplemental benefit platform offering non-emergency transportation, prescription delivery, grocery, and over the counter item benefits to Medicare Advantage, Managed Medicaid, and Commercial populations. During her 3 year tenure there, she substantially scaled the business, reimagining how technology intersects with healthcare. Prior to Uber Health, she served as Chief Operating Officer and VP Operations in a variety of businesses focused on medical transportation, home health, multi-clinic providers and post-acute care. Early in her career, she worked as an investor at Bain Capital and at Summit Partners where she built a strong understanding of finance. She earned her bachelor's degree in Economics from Harvard University and lives in Dover, Massachusetts with her husband and two boys.
Adaeze Enekwechi, CEO, Cayaba Care
Adaeze Enekwechi, PhD, MPP is the CEO of Cayaba Care maternal health company focused on improving outcomes for moderate and high risk pregnant women covered by Medicaid and commercial insurance. Cayaba provides a full-suite, wrap-around services model in the home, in person and virtually to supplement existing OB care with health related social needs during pregnancy through postpartum to ensure that women at risk experience excellent maternal outcomes. A value-based care company, Cayaba Care is focused on bridging the gaps in maternal outcomes for women in urban, rural, and often underserved communities. Dr. Enekwechi is also an Operating Partner at WCAS, an investment firm where she focuses on growth-oriented healthcare companies. She sharpens the firm's understanding of the policy and regulatory environment which can have a significant impact on healthcare companies particularly companies serving Medicare and Medicaid populations. Dr. Enekwechi is trained in health economics and outcomes research, and led IMPAQ, LLC, a company that provided research, technical assistance, and advanced analytics services for federal clients which she led through its M&A process and acquisition in 2020. She also spent many years in federal policy roles at the Congressional Budget Office (CBO), the Medicare Payment Advisory Commission, and she was the Head of Health Programs at the White House Office of Management and Budget under President Obama. There she led policy, management and regulatory oversight for all US health care agencies and programs including CMS, FDA, NIH, CDC and HRSA. Dr. Enekwechi serves on the board of directors at MedStar Health, Liberty Dental Plan, and the Alliance for Health Policy. She is based in the Washington, DC area.
Brenton Fargnoli, MD, Partner, Lightspeed Venture Partners
Brenton joined Lightspeed as a Partner in 2025 to lead Healthtech investing at the firm, with a particular focus on AI’s role in reshaping the healthcare landscape. Previously, he worked closely with Kevin Ryan, the”Godfather of NYC tech,” at AlleyCorp where he started its Healthcare team and led it to become the most active Healthtech investor in the country (per HSBC Annual Venture Healthcare Report 2024). At AlleyCorp, Brenton served as first investor and board member in value-based care startups like Thyme Care and Pearl Health and healthcare AI startups like Clarium Health. Prior to AlleyCorp, Brenton was an early employee at Flatiron Health and helped build its value-based care business from the ground up, served on its leadership team through acquisition by Roche for ~$2B, and was instrumental in the launch of OneOncology which went on to be acquired by AmerisourceBergen and TPG for ~$2B. He also worked previously at J.P. Morgan in its Healthcare Investment Banking Division, as well as at Blue Cross & Blue Shield. Brenton started his career as a physician. Board-certified in Internal Medicine, he previously practiced at Memorial Sloan Kettering Cancer Center and completed residency at Harvard’s Brigham and Women’s Hospital. He graduated summa cum laude from the University of Pennsylvania, earning an MD from the University of Pennsylvania School of Medicine and an MBA in Healthcare Management from the Wharton School. While practicing medicine, Brenton was struck by how antiquated the technology stack is for healthcare delivery - from pagers to faxes to electronic health records. At the first startup he joined, Flatiron Health, he saw the important role venture capital played in its outsized growth. From his time practicing and operating in startups, he was convinced that venture capital was the vehicle to drive the innovation healthcare technology so direly needs, and ultimately create a new standard of care delivery for patients. A long-time champion of the “Doctorpreneur” community, Brenton immediately felt at home with Lightspeed’s like-minded doctors on the Healthcare investment team and physician entrepreneurs within the portfolio such as with Abridge and Aledade. Based in New York City, Brenton is an avid supporter of the New York healthcare ecosystem and serves on the boards of Fund for Public Health NYC, Digital Health New York, and was named Crain’s New York 40 under 40
Rushika Fernandopulle, MD, MPP, Faculty Member, Harvard Medical School
Rushika Fernandopulle is a practicing physician and Chief Innovation Officer of One Medical, a leading Advanced Primary Care company based in San Francisco, CA. Before this, he was co-founder and CEO of Iora Health, was the first Executive Director of the Harvard Interfaculty Program for Health Systems Improvement, and Managing Director of the Clinical Initiatives Center at the Advisory Board Company. He is a member of the Albert Schweitzer, Ashoka, Aspen, and Salzburg Global Fellowships, and is co-author or editor of several publications. He serves on the staff at the Massachusetts General Hospital, on the faculty of Harvard Medical School. He earned his A.B., M.D., and M.P.P. from Harvard University, and completed his clinical training at the University of Pennsylvania and the Massachusetts General Hospital.
Keith J. Figlioli, Managing Partner, LRVHealth
Keith J. Figlioli joined LRVHealth in 2016, as a General Partner after nearly two decades of experience building and growing healthcare IT and services companies. Before joining LRVHealth, Keith was Senior Vice President of Healthcare Informatics at Premier, Inc. (NASDAQ: PINC) where he led the company’s enterprise healthcare technology business unit and helped the company raise $820M in its IPO. Prior to Premier, Keith was Senior Vice President of Enterprise Solutions at Eclipsys (acquired by Allscripts NASDAQ: MDRX). He is a board member of IntelyCare, Upfront Healthcare, Season Health, Censinet, and Reimagine Care, and a board observer for Diana Health, Genome Medical, and Xealth. He previously served on the Board of Trustees at Wheaton College, the Strategy Committee of Baystate Health, the Health IT Standards Committee for the Office of the National Coordinator (ONC), and the board of directors for Global Healthcare Exchange (GHX), Activate Networks, Good Sports, and MassBike. Keith earned his B.A. from Wheaton College, M.B.A. from Boston University, and M.P.H. from Harvard T.H. Chan School of Public Health.
Robert A. Garber, Managing Partner, 7wireVentures
Robert is currently a Managing Partner at 7wire Ventures, where he focuses on investments in digital healthcare and technology-enabled services that empower consumers to be better stewards of their health in today’s changing healthcare ecosystem. Robert currently sits on the boards of Cylinder Health, GroundGame.Health, Homethrive, and RecoveryOne. Robert has over 30 years of experience investing in, advising, and operating early-stage healthcare and technology companies and has co-managed five venture funds with $600M+ AUM. Before joining 7wire Ventures, Robert served as Managing Director of Stratus Ventures and KB Partners where he led investments in early-stage healthcare and technology companies. Previously, Robert held key executive roles for three high-growth companies where he led operations, business development, and finance in the ecommerce and software industries. Robert received a Master of Business Administration degree from the Kellogg Graduate School of Management and a Bachelor of Arts degree from the University of Pennsylvania.
Joseph Hammer, Head, North America Life Sciences & Healthcare, CIBC Innovation Bank
Joe Hammer has over two decades of experience in the financial services and healthcare industries. He leads the Life Science and Healthcare practice for CIBC Innovation Banking. Previously, he was the Managing Director of Silicon Valley Bank’s Life Science and Healthcare Corporate Banking practice, working with middle-market private and public companies across the U.S. Prior to SVB, Joe was the Chief Development Officer at a life sciences subsidiary specializing in business process outsourcing for orphan drug, biopharma, and medical device manufacturers.
Julian Harris, MD, Operating Partner, Health Care Services & Technology, Deerfield Management
Julian Harris, M.D., is an Operating Partner on the Healthcare Services team at Deerfield and joined the Firm in 2019. Dr. Harris works with a variety of health care services and technology companies that are both current and potential investment partners. He is also Chairman and Chief Executive Officer of ConcertoCare, a leading tech-enabled, value-based care provider of at-home comprehensive care for seniors with unmet health, behavioral and social needs. Before Deerfield, Dr. Harris was the founding President of CareAllies, Cigna’s family of multi-payer provider services and home-based care businesses. Previously, he led US Strategic Operations for Cigna and managed a $500M internal investment portfolio focused on technology and innovation. Dr. Harris was also an Adviser to Google Ventures (GV) focused on health care services. Before GV, he led the health care team in the White House Office of Management and Budget (OMB). As the federal government’s chief health care finance official, he oversaw a $1 trillion budget and provided management and policy oversight for a range of programs, including Medicare, Medicaid, FDA, NIH and CDC. He also served as the chief executive of the $11 billion Massachusetts Medicaid program. Dr. Harris trained in internal medicine and primary care at Harvard Medical School’s Brigham & Women’s Hospital and practiced as a hospitalist at Cambridge Health Alliance and as a clinical consultant for the digital second opinion company, BestDoctors (acquired by Teladoc). He graduated summa cum laude with a B.A. in Health Policy & Medical Ethics from Duke University and holds an M.Sc. from Oxford University, where he studied as a Rhodes Scholar. He is also a graduate of the Wharton School of Business and the University of Pennsylvania’s School of Medicine, where he currently serves as an Adjunct Professor. Dr. Harris is a trustee of the New York Academy of Medicine and a member of the advisory board for the Leonard Davis Institute for Health Economics at Penn.
Marc Harrison, MD, Co-Founder & CEO, Health Assurance Transformation Company (HATCo)
Marc Harrison, M.D. is a global healthcare leader, recognized for healthcare transformation and health equity advocacy. He is a pediatric critical care physician, and is the former president and CEO of Intermountain Healthcare. Dr. Harrison has joined the venture capital firm Gener Catalyst to launch and lead Health Assurance Transformation Company (HATCo), a new business with the mission to deliver health and wellness collaboratively, compassionately, and courageously - for all people. As president and CEO of Intermountain, Dr. Harrison led the organization to reimagine healthcare operations and champion innovation and collaboration to ensure that its 60,000 caregivers had access to the technology and tools to best reach, serve, and empower patients. In his first five years leading the organization, he executed a disciplined growth strategy significant investments in telehealth and rural health to expand Intermountain’s service ar from primarily Utah communities to serving patients throughout the Mountain West. Under his leadership, Intermountain embraced unconventional, public-private partnerships to confront some of the most pressing systemic challenges facing communities and industry to proactively keep people well and make communities healthier. Those initiatives were a catalyst for the national movement toward value-based care, advancing clinical education, and establishing a new Digital Hippocratic Oath (developed by Graphite, a company co-founded by Intermountain) to improve hospital data interoperability and secure patient privacy rights. During his tenure, Intermountain partnered with more than 1,000 hospitals nationwide to launch Civica Rx, a nonprofit generic drug manufacturer and distributor, to make gener medications-including insulin, which they plan to offer in 2024-more accessible and afforda Intermountain was a founding member of the Utah Alliance for the Determinants of Health, a collaboration of community partners proactively addressing forces that affect people’s ability stay healthy. Additionally, Intermountain partnered with an international genomics leader and more than 100,000 volunteers to advance medical breakthroughs that will help prevent and treat genetic diseases for people around the globe. Before leading Intermountain, Dr. Harrison served as CEO of Cleveland Clinic Abu Dhabi, chief of international business development at Cleveland Clinic, and chief medical operations officer Cleveland Clinic. Fortune recognized him as one of the Top 50 World’s Greatest Leaders in 2019, and Modern Healthcare has consistently recognized him among the Most Influential People Healthcare. Dr. Harrison is the author of Possibility Unleashed: Pathbreaking Lessons for Making Change Happen in Your Organization and Beyond, a guide for leaders to face their fears, transcend discord and polarization, and drive positive systemic and societal change. Dr. Harrison received his undergraduate degree from Haverford College and his medical degree from Dartmouth Medical School. He completed a pediatric residency and pediatric critical care fellowship at Intermountain’s Primary Children’s Hospital, and earned a Master of Medical Management at Carnegie Mellon University. He is an all-American triathlete, and represented the U.S. at the 2014 World Championships. He is also a two-time cancer survivor and nine-time Ironman participant. He is a loving husband and proud father of three adult children.
Zeena Johar, Entrepreneur in Residence, Frist Cressey Ventures
Zeena Johar joined Frist Cressey Ventures as an Entrepreneur in Residence to further her passion to continue serving vulnerable populations on Medicaid by leveraging innovative technology enabled solutions. As a healthcare entrepreneur Zeena has dedicated her career to building companies for the underprivileged, underserved and the vulnerable. Previously, Zeena was with Rubicon Founders where she Co-Founded Imagine Pediatrics (IP) along with Oak HC/FT and Optum Ventures. IP as a pediatric value-based care company, works to support the sickest-of-sick kids, by providing them 24*7 virtual and in-person support. As the Chief Growth Officer, Zeena led Imagine’s strategic partnerships with Centene and United Healthcare across TX and FL. Before joining Rubicon, Zeena led operations at Advantia Health. Advantia is now one of the largest Women's Health roll-ups with 50 Offices (across 4 States plus district) and >200 Obstetrics & Gynecology providers. Before joining Advantia Health, Zeena worked in health policy with Dr. Mark McClellan (previous FDA Commissioner & CMS Administrator). In 2007, Zeena Co-Founded SughaVazhvu Healthcare (SVHC) along with Dr. Nachiket Mor in India. SVHC, as first-of-its-kind technology enabled primary care platform, set-up clinics in rural India to support disease management for chronic conditions such as diabetes and hypertension. As CEO in 8 years, Zeena grew SVHC to 10 primary-care clinics, serving >100K patients visits. SVHC was showcased as a Case Study by The Brookings Institute. SVHC was also awarded the NASSCOM Social Innovation Honor 2014 for its innovation in healthcare delivery and use of mobile technologies. Zeena received her PhD in Molecular Diagnostics from ETH, Zurich, Switzerland. Zeena is a Harvard Business School alum (Program for Leadership Development) and was elected as an Ashoka Fellow in 2013, Aspen Global Leadership Network (AGLN) Fellow 2014, as one of Asia’s 100 Pioneers by Purpose Economy in 2014 and Yale World Fellow 2015.
Chris Johnson, Founder & CEO, Bluebird Kids Health
Chris Johnson is the founder and CEO of Bluebird Kids Health, a pediatric primary care organization serving over 20,000 patients. Through value-based care partnerships with payers, Bluebird Kids Health delivers comprehensive care by integrating physical, mental, and social health services. Its innovative clinical model is supported by a population health technology platform, which ensures proactive access to care tailored to the needs of each child. Before founding Bluebird Kids Health, Chris served as the Chief Executive Officer of Landmark Health, an organization specializing in in-home primary care for seniors with serious illnesses in value-based partnerships with Medicare Advantage plans. Under his leadership, Landmark expanded its operations from 10 to 38 states and grew its patient base from approximately 150,000 to 700,000. Chris also guided the organization through its integration with Optum, where Landmark became a cornerstone of Optum’s Home and Community portfolio. Chris resides in Newton, Massachusetts with his wife, Devon, and their three young children. In his free time, he enjoys exploring the outdoors with his family.
Jeffrey L. Kang, CEO, WellBe Senior Medical
Dr. Kang is a progressive Healthcare and Physician executive with diverse and extensive experience in multiple health care settings including health insurance, a globally capitated “medical home," the federal government and retail health care. Skilled in policy, program and product development, operations, turnaround, business development and running successful P&L’s. Uniquely positioned to run a full risk, globally capitated physician group or a health plan strategically aligned with healthcare providers. Reputation for strategic acumen and translating strategic direction into new business models and growth.
Aditi Mallick, Former CMO of Medicaid and Director of Minority Health at CMS
Dr. Aditi Mallick most recently served in senior leadership roles at the Center for Medicare and Medicaid Services (CMS), including Director of Clinical Strategy, Director of the Office of Minority Health (the health equity office within CMS), and Chief Medical Officer for Medicaid and CHIP. Her work focused on clinical strategy and cross-agency work on health equity, social determinants of health, value-based care, maternal health, behavioral health, and quality measurement among other areas. Prior to CMS, Dr. Mallick ran statewide COVID-19 response efforts for the North Carolina Department of Health and Human Services and was an engagement manager in the healthcare practice at McKinsey & Co. Dr. Mallick brings her experience caring for patients to her work. She earned her A.B. with honors from Harvard College, her M.D. from Stanford University School of Medicine, and completed internal medicine residency at Massachusetts General Hospital and Harvard Medical School before serving on the clinical faculty at Johns Hopkins and George Washington University Hospitals.
Holly Maloney, Managing Director, General Catalyst
Holly Maloney is a career-long investor and serves as managing director at venture capital firm General Catalyst. At GC, Holly co-leads the healthcare team and invests in companies across stages. Her portfolio of investments includes Maven, Capital RX, Equip, Sondermind, Fabric, Teamworks, Transcarent, Fay, Zarminali, Adonis, Sprinter, Cartwheel, Rippl Care, Evvy, InStride, Newdays.AI, and Sage Care. Holly received a BA in Economics from Bowdoin College, where she is now a Trustee and member of its Investment Committee. She lives in Marin County, CA with her husband, two daughters and golden retriever.
Danny Metzger-Traber, VP of Strategic Business Operations, Mass General Brigham Healthcare at Home
Danny Metzger-Traber is Vice President of Strategic Business Operations for Mass General Brigham Healthcare at Home, overseeing strategic direction for home-based service lines, including one of the nation’s largest Home Hospitals and New England’s largest Home Care agency. He previously held senior strategy roles at the Massachusetts Medicaid Agency and Optum. As a healthcare consultant at Oliver Wyman, Danny drove enterprise strategy development across payers, providers and life sciences companies. Danny specializes in expanding value-based care, integrating clinical and technology assets, and scaling home-based care solutions.
Mary V Presti, Corporate Vice President, Health and Life Sciences, Microsoft Corp
I have spent over 20 years across multiple sectors of healthcare, ranging from clinical to commercial, health policy to technology. I am attracted to roles that drive growth and change, and to missions that apply innovation to improve the state of our healthcare industry. I have returned businesses to growth by transforming portfolios, aligning across organizations, and building strong teams. I execute strategically. That means I design the strategy if there isn’t one, refine it if it’s not quite right, socialize it so everyone is clear on the north star, identify competencies and metrics for organizational rigor, and operationalize it so we execute successfully. I am accountable for results, and proactively manage the P&L with an eye on top and bottom line growth. I build a culture that empowers others to be accountable, while having fun. I have demonstrated success navigating complex organizations, and have made a career out of driving change from within the extra-complex ecosystem that is healthcare. I have found that doing so requires a high level of optimistic fortitude. Consider me a happy warrior for change.
Mike Pykosz, Co-Founder & Former CEO, Oak Street Health
Mike Pykosz is the co-founder and former Chairman and Chief Executive Officer of Oak Street Health, a leading network of primary care centers that delivers value-based care to adults on Medicare. Under Mike’s leadership, Oak Street Health’s team of more than 6,000 Oakies is rebuilding healthcare as it should be. His strategic guidance enabled the organization’s growth to more than 250 centers across 27 states since its founding in 2012. In May of 2023, Oak Street was acquired by CVS for $10.6 B. Following the acquisition, Mike served as EVP and President of Health Care Delivery at CVS until his departure in Dec, 2024. In this role, he oversaw strategy and operations and across CVS Health’s health care delivery assets. Mike was recognized as one of Modern Healthcare’s “100 Most Influential People in Healthcare” in 2023 for the fourth consecutive year, and one of Business Insider’s “100 People Transforming Business” in 2020.Prior to founding Oak Street Health, Mike served as a core member of the Payers and Providers practice at The Boston Consulting Group, where he led projects focused on caring for the Medicare population and their unique healthcare needs. Mike has a BS in Biochemistry from the University of Notre Dame and holds a JD from Harvard Law School.
Alyssa Reisner, Partner, Ventures, CVS Health
As a Partner and Executive Director at CVS Health Ventures, I lead the early and mid-stage investment program in digital health start-ups. I aim to make an impact through bridging the gap between CVS Health and the start-up ecosystem, and driving meaningful partnerships that bring new digital experiences to users in healthcare. I have led investments and partnership execution in areas spanning virtual specialty care, women's health, behavioral health, digital therapeutics, and more. I am passionate about digital innovation in healthcare and its potential to improve lives and outcomes.
Maya R. Said, ScD, Founder & CEO, Outcomes4Me
Dr. Said is the Founder and CEO of Outcomes4Me, a health technology company focused on empowering cancer patients with personalized, evidence-based navigation and improving outcomes through better access to innovation. Prior to founding Outcomes4Me, she was Senior Vice President of Global Market Access & Policy at Novartis Pharmaceuticals and Vice President of Strategy & External Innovation at Sanofi. Dr. Said is a strong advocate for life sciences innovation and serves on the Board of Directors of Transgene, Pieris Pharmaceuticals, and Home Biosciences. She was a founding member of the Boston Consulting Group Strategy Institute. Dr. Said trained at the Massachusetts Institute of Technology, earning dual degrees in Biology and Electrical Engineering and Computer Science with a minor in Economics. She also holds a Master of Science in Toxicology, a Master of Engineering in Electrical Engineering, and Computer Science, and a Doctor of Science in Electrical Engineering, Computer Science, and Systems Biology, all from MIT.
Martin Seneviratne, Co-Founder, Phare Health
Our mission at Phare Health is to make reimbursement fair and transparent so that healthcare organizations can spend more time focusing on patients and less time on negotiating price tags. We've assembled some of the best AI talent in the world to tackle the hardest challenges in revenue cycle, beginning with complex medical coding. Before Phare, I helped build data-driven electronic health record products at Google and DeepMind, trained in informatics at Stanford, and worked as a doctor in Australia.
Michelle Snyder, Partner, McKesson Ventures
Michelle Snyder brings over 25 years’ healthcare industry experience in marketing, business development, strategic planning, public policy, and general management. Prior to joining McKesson Ventures, she was Chief Marketing Officer at Welltok as well as an early executive at Epocrates, where she worked for over a decade to build the company into one of the most recognized brands among clinicians. Her MV investments include CancerIQ, Galileo, Inbound Health, Reimagine Care, and RxVantage. Michelle has also served as an Executive-in-Residence at InterWest Partners, investing in digital health companies and advising portfolio companies. In addition, she has held consulting and policy positions at The Wilkerson Group, the Lewin Group and the Georgetown Center for Health Policy Studies. Michelle earned her M.B.A. at the Kellogg School of Management at Northwestern University and her B.A. from Carleton College. Though she’s been in the Bay Area for over 20 years, she still dons green and gold and wears her Cheesehead proudly on Sundays.
Sharif Vakili, Co Founder & CEO, UpDoc
Sharif is a healthcare executive, physician and clinician educator. He is the co-founder and CEO of UpDoc, a healthcare AI company pioneering a model of clinician-supervised AI care delivery known as Remote Patient Intervention (RPI). Sharif is also a primary care physician on faculty at Stanford and an investor at Polaris Partners, where he focuses on digital health and life sciences investments.
Megann Vaughn Watters, Vice President, New Ventures & Strategic Alliances, Labcorp
Megann Vaughn Watters is an experienced corporate development executive and investor with over 10 years of novel technology identification, partnership development, deal execution, alliance management, financial and strategic return, and venture-backed board experience within the healthcare industry. As the Vice President of New Ventures & Strategic Alliances at Labcorp, Megann manages the Labcorp Venture Fund and leads the Corporate Development team tasked to identify, assess, and bring innovative science and technology to Labcorp through partnerships, such as equity investments, licensing, commercial collaborations. Megann previously held positions at the United States Patent and Trademark Office as a Patent Examiner for medical devices and Humacyte conducting tissue engineering research. Megann received her M.B.A. from the Duke University Fuqua School of Business and her B.S.E. in Biomedical Engineering from Duke University Pratt School of Engineering.
Jessica A. Zeaske, PhD, Partner, Echo Health Ventures
As a Partner at Echo Health Ventures in Boston, Jessica A. Zeaske, PhD, MHS, MBA, identifies and invests in emerging and growth stage companies for Echo. She is a seasoned venture capitalist and board leader having worked at independent, corporate, and university funds and written dozens of investment themes over the years. She previously served as Director of Healthcare Investments at GE Ventures where she invested in precision health companies. Jessica came to GE Ventures from Lemhi Ventures, a fund investing in health care services with a focus on market disruption. Prior to joining Lemhi, Jessica worked on forming and spinning out MedTech and Life Science companies based on University intellectual property at U of Minnesota and Oregon Health & Science University. Jessica began her career writing software for a start-up health care delivery company. She then moved to a merchant bank, Greenspring Advisors, where they launched and invested in data-driven health care start-up companies. Jessica received an undergraduate degree with honors from Stanford University, graduated from Johns Hopkins School of Public Health with a Master of Health Science and PhD, and completed her MBA with a focus on Healthcare Administration at Regis University. Jessica currently serves on the Boards of Avalon Healthcare Services, Genome Medical and Wildflower Health and is a Board Observer at Abacus Insights. Her previous Board of Director experience includes Apervita, Arcadia.io, PlanSource, OneHealth, PokitDok, Orasi Medical, Medication Management Solutions, plus significant work at Bind On-Demand Health Insurance. Jessica also serves on the Board of DentaQuest Partnership for Oral Health Advancement, is a Trustee for Boston Medical Center's Exceptional Care Without Exception Trust, is an Advisory Board member for Boston Children's Hospital, and is a member of the National Association of Corporate Directors.